Drug Trial Radar · NCT05329194
Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States
Last checked: Nov 20, 2026Latest source record: Jul 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
286
Actual
Start
Apr 29, 2022
Primary completion
Oct 1, 2025
Study completion Oct 1, 2025
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Parexel
- First posted
- Apr 14, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied populations in the United States.
Conditions
- Asthma
Interventions
TezepelumabDrug
Participants will be receiving subcutaneous injection of tezepelumab.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Asthma Exacerbation Rate (AAER)Time frame: Baseline period (Week -52 to Week 0), Study period (Week 0 to Week 52)
Locations
37 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Mobile, Alabama
Research Site
Gilbert, Arizona
Research Site
Long Beach, California
Research Site
Los Angeles, California
Research Site
Rancho Mirage, California
Research Site
Westminster, California
Research Site
Colorado Springs, Colorado
Research Site
New Haven, Connecticut
Research Site
Washington D.C., District of Columbia
Research Site
Chicago, Illinois
Research Site
Lexington, Kentucky
Research Site
New Orleans, Louisiana
Research Site
Upper Marlboro, Maryland
Research Site
Ann Arbor, Michigan
Research Site
Ypsilanti, Michigan
Research Site
Saint Paul, Minnesota
Research Site
St Louis, Missouri
Research Site
Lincoln, Nebraska
Research Site
Omaha, Nebraska
Research Site
Hollis, New York
Research Site
Horseheads, New York
Research Site
Rochester, New York
Research Site
Valhalla, New York
Research Site
Chapel Hill, North Carolina
Research Site
Wilmington, North Carolina
Research Site
Toledo, Ohio
Research Site
Oklahoma City, Oklahoma
Research Site
Altoona, Pennsylvania
Research Site
Philadelphia, Pennsylvania
Research Site
Warwick, Rhode Island
Research Site
Greenville, South Carolina
Research Site
Hendersonville, Tennessee
Research Site
Fort Worth, Texas
Research Site
McKinney, Texas
Research Site
San Antonio, Texas
Research Site
Charlottesville, Virginia
Research Site
Vancouver, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.